{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:20Z","timestamp":1761959600370,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":222,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.lrr.2022.100343","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T12:14:26Z","timestamp":1660306466000},"page":"100343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-557X","authenticated-orcid":false,"given":"Minh Phuong","family":"Vu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Quang","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuc Nhung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lrr.2022.100343_bib0001","first-page":"231","article-title":"Cytogenetic abnormalities in myelodysplastic syndrome","volume":"11","author":"Zahid","year":"2017","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"issue":"13","key":"10.1016\/j.lrr.2022.100343_bib0002","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2022.100343_bib0003","article-title":"Diagnosis and classification of myelodysplastic syndrome","author":"Hamid","year":"2019","journal-title":"Intechopen"},{"issue":"43","key":"10.1016\/j.lrr.2022.100343_bib0004","doi-asserted-by":"crossref","first-page":"73483","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre- MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.lrr.2022.100343_bib0005","doi-asserted-by":"crossref","first-page":"838","DOI":"10.6004\/jnccn.2013.0104","article-title":"Myelodysplastic syndromes. Clinical practice guidelines in oncology","author":"Greenberg","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"3","key":"10.1016\/j.lrr.2022.100343_bib0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/jtim-2017-0002","article-title":"The 2016 revision to the World Health Organization classification of myelodysplastic syndromes","author":"Hong","year":"2017","journal-title":"J. Transl. Int. Med"},{"issue":"14","key":"10.1016\/j.lrr.2022.100343_bib0007","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-01-330126","article-title":"A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-\/Intermediate-1-risk myelodysplastic syndromes with del5q","volume":"118","author":"Fenaux","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.lrr.2022.100343_bib0008","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.lrr.2022.100343_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jare.2018.02.002","article-title":"Cytogenetic features in primary myelodysplastic syndrome Egyptian patients","volume":"10","author":"Elnahass","year":"2018","journal-title":"J. Adv. Res."},{"issue":"8","key":"10.1016\/j.lrr.2022.100343_bib0010","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood-2005-01-0040","article-title":"Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes","volume":"106","author":"Matsuda","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2022.100343_bib0011","unstructured":"Mitelman F. ISCN 1995 guidelines for cancer cytogenetics supplement to: an international system for human cytogenetic nomenclature (S. Karger, Basel). Google Scholar."},{"issue":"11","key":"10.1016\/j.lrr.2022.100343_bib0012","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: international working group on morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblast and ring sideroblast","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.lrr.2022.100343_bib0013","first-page":"632","article-title":"Chromosomal abnormalities in primary myelodysplastic syndrome","volume":"24","author":"Rashid","year":"2014","journal-title":"JCPSP"},{"issue":"12","key":"10.1016\/j.lrr.2022.100343_bib0014","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","article-title":"Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities","volume":"113","author":"Pozdnyakova","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lrr.2022.100343_bib0015","first-page":"452","article-title":"Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes","volume":"134","author":"Chaubey","year":"2011","journal-title":"Indian J. Med. Res."},{"issue":"12","key":"10.1016\/j.lrr.2022.100343_bib0016","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.leukres.2008.05.002","article-title":"Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations","volume":"32","author":"Gmidene","year":"2008","journal-title":"Leuk. Res"},{"issue":"9","key":"10.1016\/j.lrr.2022.100343_bib0017","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.leukres.2008.11.021","article-title":"Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients","volume":"33","author":"Li","year":"2009","journal-title":"Leuk. Res."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:09:06Z","timestamp":1761959346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048922000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":17,"alternative-id":["S2213048922000553"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100343","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100343"}}